Cargando…

Downregulation of miR-22 Contributes to Epithelial-Mesenchymal Transition in Osteosarcoma by Targeting Twist1

The epithelial-mesenchymal transition (EMT) is a vital step in osteosarcoma (OS) progression toward metastasis, but the specific molecular events governing this process are incompletely characterized, with miRNAs having increasingly been found to regulate the EMT. In this study, We assessed levels o...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Shu-tao, Wang, Xiao, Wang, Jun-yi, Xi, Guang-hui, Liu, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193700/
https://www.ncbi.nlm.nih.gov/pubmed/32391253
http://dx.doi.org/10.3389/fonc.2020.00406
_version_ 1783528239794225152
author Zhu, Shu-tao
Wang, Xiao
Wang, Jun-yi
Xi, Guang-hui
Liu, Yang
author_facet Zhu, Shu-tao
Wang, Xiao
Wang, Jun-yi
Xi, Guang-hui
Liu, Yang
author_sort Zhu, Shu-tao
collection PubMed
description The epithelial-mesenchymal transition (EMT) is a vital step in osteosarcoma (OS) progression toward metastasis, but the specific molecular events governing this process are incompletely characterized, with miRNAs having increasingly been found to regulate the EMT. In this study, We assessed levels of miR-22 and its target, Twist1, via real-time PCR (qRT-PCR). We further used functional proliferation assays, measures of cell morphology, and western blotting to assess the functional relevance of miR-22 in OS and confirmed Twist1 as a miR-22 target via luciferase reporter assay. We observed a significant decrease in miR-22 levels in OS tumor samples relative to normal tissue, with such downregulating being significantly associated with tumor histological grade. When overexpressed, miR-22 impaired OS cell proliferation and EMT progression. We found Twist1 to be a direct miR-22 target, with levels of miR-22 and Twist1 mRNA being inversely correlated in patient samples. When overexpressed, miR-22 suppressed Twist1 translation and thereby attenuated the EMT in OS cells. These results clearly demonstrate that miR-22 can regulate the EMT in OS cells via targeting Twist1, thus highlighting a potentially novel pathway that can be therapeutically targeted in order to treat OS.
format Online
Article
Text
id pubmed-7193700
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-71937002020-05-08 Downregulation of miR-22 Contributes to Epithelial-Mesenchymal Transition in Osteosarcoma by Targeting Twist1 Zhu, Shu-tao Wang, Xiao Wang, Jun-yi Xi, Guang-hui Liu, Yang Front Oncol Oncology The epithelial-mesenchymal transition (EMT) is a vital step in osteosarcoma (OS) progression toward metastasis, but the specific molecular events governing this process are incompletely characterized, with miRNAs having increasingly been found to regulate the EMT. In this study, We assessed levels of miR-22 and its target, Twist1, via real-time PCR (qRT-PCR). We further used functional proliferation assays, measures of cell morphology, and western blotting to assess the functional relevance of miR-22 in OS and confirmed Twist1 as a miR-22 target via luciferase reporter assay. We observed a significant decrease in miR-22 levels in OS tumor samples relative to normal tissue, with such downregulating being significantly associated with tumor histological grade. When overexpressed, miR-22 impaired OS cell proliferation and EMT progression. We found Twist1 to be a direct miR-22 target, with levels of miR-22 and Twist1 mRNA being inversely correlated in patient samples. When overexpressed, miR-22 suppressed Twist1 translation and thereby attenuated the EMT in OS cells. These results clearly demonstrate that miR-22 can regulate the EMT in OS cells via targeting Twist1, thus highlighting a potentially novel pathway that can be therapeutically targeted in order to treat OS. Frontiers Media S.A. 2020-04-24 /pmc/articles/PMC7193700/ /pubmed/32391253 http://dx.doi.org/10.3389/fonc.2020.00406 Text en Copyright © 2020 Zhu, Wang, Wang, Xi and Liu. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Zhu, Shu-tao
Wang, Xiao
Wang, Jun-yi
Xi, Guang-hui
Liu, Yang
Downregulation of miR-22 Contributes to Epithelial-Mesenchymal Transition in Osteosarcoma by Targeting Twist1
title Downregulation of miR-22 Contributes to Epithelial-Mesenchymal Transition in Osteosarcoma by Targeting Twist1
title_full Downregulation of miR-22 Contributes to Epithelial-Mesenchymal Transition in Osteosarcoma by Targeting Twist1
title_fullStr Downregulation of miR-22 Contributes to Epithelial-Mesenchymal Transition in Osteosarcoma by Targeting Twist1
title_full_unstemmed Downregulation of miR-22 Contributes to Epithelial-Mesenchymal Transition in Osteosarcoma by Targeting Twist1
title_short Downregulation of miR-22 Contributes to Epithelial-Mesenchymal Transition in Osteosarcoma by Targeting Twist1
title_sort downregulation of mir-22 contributes to epithelial-mesenchymal transition in osteosarcoma by targeting twist1
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193700/
https://www.ncbi.nlm.nih.gov/pubmed/32391253
http://dx.doi.org/10.3389/fonc.2020.00406
work_keys_str_mv AT zhushutao downregulationofmir22contributestoepithelialmesenchymaltransitioninosteosarcomabytargetingtwist1
AT wangxiao downregulationofmir22contributestoepithelialmesenchymaltransitioninosteosarcomabytargetingtwist1
AT wangjunyi downregulationofmir22contributestoepithelialmesenchymaltransitioninosteosarcomabytargetingtwist1
AT xiguanghui downregulationofmir22contributestoepithelialmesenchymaltransitioninosteosarcomabytargetingtwist1
AT liuyang downregulationofmir22contributestoepithelialmesenchymaltransitioninosteosarcomabytargetingtwist1